Manifold Bio Expands Leadership Team to Drive its AI + In Vivo Targeted Biologics Platform [Yahoo! Finance]
ROCHE HOLDING LTD S/ADR (RHHBY)
NASDAQ:AMEX Investor Relations:
roche.com/investors.htm
Company Research
Source: Yahoo! Finance
pioneering AI-guided drug discovery coupled with massively multiplexed in vivo measurement, today announced the expansion of its executive leadership team with the appointment of Paula Cobb as Chief Operating Officer. Ms. Cobb is the most recent seasoned addition to the company's leadership, anchored by Co-founders Gleb Kuznetsov (CEO), Pierce Ogden (CTO), and Shane Lofgren (Head of Strategy). Earlier this year Kimberly Scearce-Levie joined as CSO, alongside industry leaders Steve Holtzman as Executive Chair and Doug Williams as Chair of the Strategic Advisory Board. This deepening of the executive bench comes at a pivotal moment as Manifold Bio scales its proprietary drug discovery engine - a deeply integrated platform that combines massive-scale in vivo data generation with cutting-edge AI-guided protein design to create tissue-targeted biologics. Built to overcome the limitations of traditional discovery approaches, Manifold's platform enables precision protein engineering acro
Show less
Read more
Impact Snapshot
Event Time:
RHHBY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RHHBY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RHHBY alerts
High impacting ROCHE HOLDING LTD S/ADR news events
Weekly update
A roundup of the hottest topics
RHHBY
News
- Roche announces U.S. launch of next-generation cobas 6800/8800 systems and software, enhancing laboratory efficiency and testing capabilitiesPR Newswire
- Calluna Pharma Announces the Appointment of Gijs van den Brink, MD, PhD, as Independent Director [Yahoo! Finance]Yahoo! Finance
- Zealand Pharma and OTR to develop metabolic disease therapeutics [Yahoo! Finance]Yahoo! Finance
- FDA proposes allowing sunscreen ingredient already used in Europe and Asia [MSNBC.com]MSNBC.com
- Roche expands automated mass spectrometry menu with antibiotics drug monitoring CE mark approval offering industry's broadest in vitro diagnostic menu [Yahoo! Finance]Yahoo! Finance